HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

K Huber Selected Research

PMX 464

8/2007A cellular and molecular investigation of the action of PMX464, a putative thioredoxin inhibitor, in normal and colorectal cancer cell lines.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


K Huber Research Topics

Disease

17Myocardial Infarction
02/2021 - 03/2000
12Thrombosis (Thrombus)
12/2014 - 04/2001
10Hemorrhage
09/2014 - 08/2001
10Acute Coronary Syndrome
01/2014 - 08/2000
9Insulin Resistance
09/2018 - 09/2001
8Inflammation (Inflammations)
10/2021 - 07/2000
8Cardiovascular Diseases (Cardiovascular Disease)
06/2013 - 09/2001
8Coronary Artery Disease (Coronary Atherosclerosis)
05/2011 - 05/2000
6ST Elevation Myocardial Infarction
02/2021 - 12/2008
6Atrial Fibrillation
08/2016 - 05/2013
5Stroke (Strokes)
08/2016 - 10/2010
4Atherosclerosis
11/2017 - 09/2001
4Hypertension (High Blood Pressure)
08/2016 - 03/2000
4Atherosclerotic Plaque (Atheroma)
06/2014 - 08/2006
4Pain (Aches)
09/2005 - 03/2000
3Diabetes Mellitus
05/2012 - 03/2000
3Unstable Angina
04/2001 - 12/2000
2Neoplasms (Cancer)
01/2017 - 03/2001
2Heart Failure
08/2016 - 02/2010
2Body Weight (Weight, Body)
01/2015 - 05/2007
2Coronary Disease (Coronary Heart Disease)
05/2013 - 11/2012
2Rupture
03/2011 - 08/2006
2Reperfusion Injury
01/2010 - 07/2000
2Postoperative Pain
09/2005 - 08/2001
2Infections
07/2002 - 03/2001
2Hypertriglyceridemia
09/2001 - 09/2001
2Systemic Inflammatory Response Syndrome (Sepsis Syndrome)
09/2001 - 07/2000
2Critical Illness (Critically Ill)
09/2001 - 07/2000
1VLCAD deficiency
10/2021
1Non-ST Elevated Myocardial Infarction
02/2021
1BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
11/2017
1Ischemia
11/2017
1Arterial Occlusive Diseases (Arterial Occlusive Disease)
11/2017
1Thromboembolism
08/2016
1Vascular Diseases (Vascular Disease)
08/2016
1Bluetongue
11/2015
1Type 2 Diabetes Mellitus (MODY)
02/2015

Drug/Important Bio-Agent (IBA)

6Plasminogen Activator Inhibitor 1IBA
02/2015 - 09/2001
6Clopidogrel (Plavix)FDA Link
06/2012 - 04/2001
5Insulin (Novolin)FDA Link
09/2016 - 05/2006
4Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
11/2012 - 09/2001
4Heparin (Liquaemin)FDA LinkGeneric
08/2010 - 12/2000
4Plasminogen InactivatorsIBA
05/2006 - 07/2001
3Biological ProductsIBA
01/2017 - 04/2000
3Glucose (Dextrose)FDA LinkGeneric
02/2015 - 05/2006
3P-SelectinIBA
02/2015 - 07/2000
3AnticoagulantsIBA
05/2014 - 05/2013
3Prasugrel HydrochlorideFDA Link
01/2014 - 08/2010
3Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
06/2012 - 04/2001
3Enoxaparin (Lovenox)FDA LinkGeneric
08/2010 - 12/2000
3CytokinesIBA
02/2010 - 07/2000
3Fibrinolytic Agents (Antithrombotic Agents)IBA
09/2001 - 04/2000
2Messenger RNA (mRNA)IBA
10/2021 - 06/2014
2AdipokinesIBA
01/2018 - 02/2015
2Apolipoproteins E (ApoE)IBA
11/2017 - 09/2001
2Biomarkers (Surrogate Marker)IBA
01/2017 - 03/2011
2RNA (Ribonucleic Acid)IBA
02/2015 - 05/2007
2Nonesterified Fatty Acids (NEFA)IBA
02/2015 - 01/2013
2Proteins (Proteins, Gene)FDA Link
02/2015 - 08/2007
2Pharmaceutical PreparationsIBA
10/2014 - 06/2013
2Lidocaine (Xylocaine)FDA LinkGeneric
09/2014 - 01/2010
2Vitamin KFDA Link
05/2014 - 06/2013
2AntigensIBA
06/2013 - 09/2001
2omega-Chloroacetophenone (Mace)IBA
04/2012 - 12/2010
2Abciximab (ReoPro)FDA Link
12/2011 - 12/2008
2Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA
05/2011 - 08/2010
2Complement System Proteins (Complement)IBA
03/2011 - 08/2006
2Macrophage Colony-Stimulating FactorIBA
02/2010 - 12/2007
2EnzymesIBA
08/2007 - 11/2000
2Tissue Plasminogen Activator (Alteplase)FDA Link
05/2006 - 09/2001
2HomocysteineIBA
01/2006 - 09/2001
2Antifibrinolytic Agents (Antifibrinolytics)IBA
09/2001 - 09/2001
2Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA
04/2001 - 12/2000
2SelectinsIBA
03/2001 - 07/2000
1Carnitine O-Palmitoyltransferase (Carnitine Palmitoyltransferase II)IBA
10/2021
1Carnitine (L-Carnitine)FDA LinkGeneric
10/2021
1Fatty Acids (Saturated Fatty Acids)IBA
10/2021
1Solute Carrier Family 22 Member 5IBA
10/2021
1Acyl-CoA Dehydrogenase (Medium-Chain Acyl-Coenzyme A Dehydrogenase)IBA
10/2021
1Troponin T (Troponin T1)IBA
02/2021
1SphingomyelinsIBA
09/2018
1Imatinib Mesylate (Gleevec)FDA Link
11/2017
1nilotinibFDA Link
11/2017
1Phosphotransferases (Kinase)IBA
11/2017
1AngiopoietinsIBA
11/2017
1ElementsIBA
09/2016
1LipopolysaccharidesIBA
01/2016
1Interleukin-18 (Interleukin 18)IBA
02/2015
1Peptide Hydrolases (Proteases)FDA Link
02/2015
1AdiponectinIBA
02/2015
1Interleukin-8 (Interleukin 8)IBA
02/2015
1Tissue Inhibitor of Metalloproteinase-1IBA
02/2015
1Butyric Acid (Butanoic Acid)IBA
01/2015

Therapy/Procedure

16Therapeutics
01/2014 - 04/2000
11Stents
12/2014 - 07/2000
6Percutaneous Coronary Intervention
12/2014 - 02/2010
6Thrombolytic Therapy
08/2010 - 04/2000
2Electric Countershock (Cardioversion)
08/2016 - 05/2013
2Tonsillectomy
09/2005 - 08/2001
2Cardiopulmonary Resuscitation (CPR)
09/2001 - 07/2000